Long-term administration of valacyclovir reduces the number of Epstein-Barr virus (EBV)-infected B cells but not the number of EBV DNA copies per B cell in healthy volunteers. (Q37410629)
Jump to navigation
Jump to search
scientific article published on 09 September 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term administration of valacyclovir reduces the number of Epstein-Barr virus (EBV)-infected B cells but not the number of EBV DNA copies per B cell in healthy volunteers. |
scientific article published on 09 September 2009 |
Statements
Long-term administration of valacyclovir reduces the number of Epstein-Barr virus (EBV)-infected B cells but not the number of EBV DNA copies per B cell in healthy volunteers (English)
Yo Hoshino
Ping Zou
Patricia Hohman
Stephen K Tyring
Dean Follmann
Jeffrey I Cohen
9 September 2009